After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

The variant, first detected in the U.S. in late March, has now been identified in arriving international travelers through ...

The requirement for placebo-controlled trials isn’t expected to affect the rollout this fall for older adults and other ...

Despite the fact that vaccines against COVID have already undergone strict safety reviews and that people continue to die ...

The US Centers for Disease Control and Prevention lists a wide range of conditions that may make someone more likely to become severely ill with Covid-19, including older age, asthma, diabetes ...

The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

The U.S. Food and Drug Administration's advisory panel is set to vote on Thursday to recommend whether COVID-19 vaccines for ...

Healthy and under the age of 65? You might not need to receive an annual COVID-19 booster. What to know about new guidelines.